Trial Profile
A Phase I Intensive Pharmacokinetic Study of Porfiromycin in Head and Neck Cancer and Other Cancer Patients With Solid Tumors Who Receive Radiation Therapy
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Aug 2014
Price :
$35
*
At a glance
- Drugs Porfiromycin (Primary)
- Indications Head and neck cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 07 Aug 2014 New trial record